Human Resources; Biotechnology & Life Sciences; Regulatory Affairs · medium ·
The expertise wedge forming under the drug-device CRL scrutiny
The demand for experienced clinical and regulatory leaders skilled in navigating complex FDA Complete Response Letters (CRLs) for drug-device combination products is increasing. This is due to pharmaceutical companies expanding R&D into new modalities like a major operator and targeted delivery, alongside more prescriptive another operator requirements from a leading provider, creating a critical shortage of talent that can proactively address regulatory hurdles in high-risk development programs.
Part of the Professional Services Opportunity Outlook, Korim's monthly analysis of emerging opportunities in this sector.
Part of the Healthcare & Life Sciences Opportunity Outlook, Korim's monthly analysis of emerging opportunities in this sector.
Part of the Technology Opportunity Outlook, Korim's monthly analysis of emerging opportunities in this sector.
Part of the People & HR Opportunity Outlook, Korim's collection of emerging opportunities in this sector.